Clarithromycin resistance test couldimprove the eradication rate of H. pylori

被引：0
|
作者：
Jung, J. [1 ]
Kwon, J. [1 ]
Kim, E. [1 ]
机构：
[1] Daegu Catholic Univ, Sch Med, Daegu, South Korea
来源：
HELICOBACTER | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1.08
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Metabolic consequences of H. pylori eradication
    Francois, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 30 - 30
  • [22] World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
    Hidekazu Suzuki
    Hideki Mori
    Journal of Gastroenterology, 2018, 53 : 354 - 361
  • [23] Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients
    Saracino, I. M.
    Pavoni, M.
    Zullo, A.
    Fiorini, G.
    Saccomanno, L.
    Lazzarotto, T.
    Cavallo, R.
    Antonelli, G.
    Vaira, D.
    ANTIBIOTICS-BASEL, 2020, 9 (03):
  • [24] EFFICACY OF REINFORCED H-PYLORI ERADICATION THERAPY IN REGION OF HIGH CLARITHROMYCIN RESISTANCE
    Zakharova, N.
    Savilova, I.
    HELICOBACTER, 2015, 20 : 92 - 92
  • [25] Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study
    Zhang, Chuanfeng
    Cao, Mengjiao
    Lv, Tangshan
    Wang, Hongyan
    Liu, Xiaoxiao
    Xie, Yong
    Lv, Nonghua
    Chen, Hongtan
    Cram, David S.
    Zhong, Jing
    Zhou, Linfu
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (08) : 1599 - 1608
  • [26] Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study
    Chuanfeng Zhang
    Mengjiao Cao
    Tangshan Lv
    Hongyan Wang
    Xiaoxiao Liu
    Yong Xie
    Nonghua Lv
    Hongtan Chen
    David S. Cram
    Jing Zhong
    Linfu Zhou
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1599 - 1608
  • [27] Assessment of Clarithromycin Susceptibility in H. pylori Strains and Factors that may Predict Resistance
    Agudo, S.
    Perez-Perez, G.
    Alarcon, T.
    Lopez-Brea, M.
    HELICOBACTER, 2009, 14 (04) : 392 - 392
  • [28] Adjusted cut-off for H. pylori antigen stool test for determination of H. pylori status after eradication.
    Leodolter, A
    Agha-Amiri, K
    Gerards, C
    Peitz, U
    Malfertheiner, P
    GASTROENTEROLOGY, 2000, 118 (04) : A697 - A697
  • [29] Effectiveness and safety of bismuth quadruple therapy (Pylera®) in combination with PPIs for the eradication of H. pylori infection in patients with dual clarithromycin and metronidazole resistance
    Fiorini, G.
    Saracino, I. M.
    Gatta, L.
    Vaira, D.
    HELICOBACTER, 2017, 22
  • [30] Accuracy of a triple molecular genetic test for H. pylori (HP) infection and its resistance to fluoroquinolones and clarithromycin: Preliminary results
    Mathou, N.
    Likousi, S.
    Paraskeva, K. D.
    Andrikopoulos, E.
    Zografos, K.
    Platsouka, E.
    Karagiannis, J. A.
    HELICOBACTER, 2010, 15 (04) : 360 - 361
12345